MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

18d ago

MNOV

PremiumCompany Announcements

MediciNova Vice President Geoffrey O’Brien Announces Retirement

19d ago

MNOV

PremiumPress Releases

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

25d ago

MNOV

PremiumPress Releases

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

1M ago

MNOV

PremiumPress Releases

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

1M ago

MNOV

PremiumPress Releases

MediciNova Receives a Notice of Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in China

3M ago

MNOV

PremiumPress Releases

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in Chlorine Gas-induced Lung Injury Accepted for Presentation at the 63rd Annual Meeting of the Society of Toxicology

4M ago

MNOV

More MNOV News >

MNOV News on the Web

2024-04-02

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166

Yahoo Finance

Neutral

2024-03-27

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace

Neutral

2024-03-27

Should You Sell Medicinova Inc (MNOV) Stock Wednesday Morning?

Investors Observer

Neutral

2024-03-26

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 for the Treatment of Macular Injury in Japan

Yahoo Finance

Neutral

2024-03-20

Companies Like MediciNova Are In A Position To Invest In Growth

Yahoo Finance

Bullish

2024-03-12

MediciNova Announces New Data and Results of MN-166 in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

Yahoo Finance

Neutral

2024-02-29

MNOV: Capital Efficient Model and Large Late-Stage Pipeline Makes MediciNova Stand Out Among Peers…

Yahoo Finance

Bullish

2024-02-20

Should You Hold Medicinova Inc (MNOV) Stock Tuesday Morning?

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNOV’s Media Buzz Sentiment?

Currently, no data Available

What is MNOV’s weekly average amount of articles?

Currently, no data Available

What is MNOV’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

ELVElevance Health

EWEdwards Lifesciences

INSPInspire Medical Systems

CGEMCullinan Management

MRNSMarinus

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing